A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)
Clinical trial NCT03694275 · COMPLETED
Trial details
- NCT number
- NCT03694275
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2020-07-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.